The murine VL3O elements constitute one family of retrotransposons represented in 100 to 200 copies that are dispersed among the mouse chromosomes. On the basis of sequence homology, we have subdivided mouse VL30 members into four distinct U3 subgroups. The use of subgroup-specific probes in Northern (RNA) blot analyses shows that individual VL30 U3 subgroups are expressed in a tissue-specific manner. We show by in situ hybridization of mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) that VL3O expression is induced in epidermal keratinocytes but not in dermal fibroblasts. Transient transfections of reporter gene plasmids together with in vitro binding analysis indicate that TPA-induced VL30 transcription specific for keratinocytes is mediated by two cooperating sequence motifs in juxtaposed position. One sequence motif is shown to constitutively bind CREB-and Jun-related proteins in both keratinocytes and fibroblasts, whereas the other is a target for TPA-induced c-Rel/p65(NF-KB)-binding activity specifically in keratinocytes. These binding sites are found to be conserved within U3 subgroups and individual U3 regions showing induced expression in TPA-treated mouse epidermis. These results together with a sequence comparison between different U3 subgroups indicate that cell type-specific activity of transcription factors known to regulate VL30 transcription and the presence or absence of their cognate binding sites within individual U3 regions determine inducible and cell type-specific VL30 expression. The variable VL30 U3 regions might thus be useful tools to study inducible and cell type-specific transcription in many different cell systems.
The long terminal repeat (LTR) is a distinctive feature that structurally unites proviruses with the broad collection of eukaryotic transposable elements known as retrotransposons (reviewed in references 5, 37, and 38). A particularly potent genetic determinant within the retroviral LTR is the U3 region which contains the transcriptional enhancer and promoter sequences. When the U3 region is viewed as an array of multiple short binding sites for numerous trans-acting proteins, it is likely that a difference in the sequence between distinct U3 regions will produce a functional change. Several studies have provided evidence for such a key role for specific U3 sequences in determining viral tissue tropism and transcriptional regulation (12, 13, 16, 40-42, 59, 67, 70) .
The murine VL30 elements constitute one family of retrotransposons represented in 100 to 200 copies that are dispersed among the mouse chromosomes (11, 15, 36, 37) . The levels of VL30 transcripts are elevated by a wide variety of agents, such as serum, growth factors, calcium, peptide hormones, glucocorticoids, retinoic acid, 12-O-tetradecanoylphorbol-13-acetate (TPA), forskolin, and cycloheximide (6-8, 19, 25, 27, 32, 39, 44, 57, 65) . Other studies have shown induction of VL30 expression in response to ionizing radiation, anoxia, and transformation caused by simian virus 40 infection or the Ha-ras oncogene (3, 19, 50, 52, 68) . Because of the heterogeneity in VL30 LTRs, it is possible that only a small fraction of the VL30 population responds to these signals. Three distinct VL30 retrotransposons (NVL3, B10, and RVL3) have been used to map specific binding sites for nuclear proteins involved in mediating transcriptional induction caused by an activated Ha-ras oncogene, TPA, forskolin, retinoic acid, epidermal growth factor, and thapsigargin (6, 7, 32, 39, 50) .
VL30 transcripts are ubiquitously expressed at relatively high levels in most somatic tissues examined (22, 27, 44, 48) . However, analysis of VL30 expression with probes that do not discriminate between different VL30 members might be misleading, in that the predominant size class (5.6 kb) of VL30 RNA probably corresponds to transcripts encoded by different VL30 elements at particular chromosomal locations and/or having unique U3 regions. By the use of S1 nuclease mapping experiments, which distinguish transcripts from distinct VL30 elements, Norton and Hogan have shown both temporal and tissue specific expression of VL30 elements during mouse development (48) . It was recently shown by Schiff et al. that VL30 retrotransposons are specifically expressed in steroidogenic cells within all four endocrine tissues engaged in synthesis of steroid hormones in response to their respective pituitary-derived trophic hormone (65) . Two related VL30 LTRs which contained hormone-responsive enhancers were cloned from ovaries stimulated with luteinizing hormone. Further support for distinct transcriptional regulation of different VL30 LTRs has come from studies showing that the transcriptional efficiencies mediated by VL30 LTRs differ when analyzed in the same cell type (61) . Moreover, induced transcription in response to serum addition is correlated with a specific U3 sequence variant, whereas transformation induces the expression of additional types of VL30 elements (19) .
In this study, we have analyzed the relationship between the structural diversity in the U3 region and cell type-specific regulation of VL30 transcription. We have divided sequenced VL30 U3 regions into four U3 subgroups that possess distinct conserved sequence motifs known to be involved in cell type-specific transcriptional regulation. By the use of subgroup-specific probes in Northern (RNA) analysis, it was revealed that U3 subgroups showing high levels of expression in either muscle tissues or spleen specifically contained conserved sequence motifs known to be involved in muscle-and lymphoid-specific transcription, respectively. Furthermore, ke-ratinocyte-specific c-Rel/NF-KB-binding activity to a distinct TPA response element was found to correlate with keratinocyte-specific transcriptional regulation in cultured cells and the presence of this TPA response element within VL30 U3 regions correlated with TPA-induced expression in keratinocytes in mouse skin in vivo. These results indicated that the specific enhancer design of the individual U3 subgroup determined in which cell type it was expressed or activated in response to extracellular signals.
MATERIALS AND METHODS
Cell culture conditions. All chemicals and media were purchased from Sigma, unless stated otherwise. The mouse fibroblast cell line Swiss/3T3 was cultured in Dulbecco's modified Eagle's medium (GIBCO) containing 10% (vol/vol) fetal calf serum (Hyclone), 100 IU of penicillin per ml, 100 ,ug of streptomycin per ml, and 0.25 ,ug of amphotericin B (Fungizone) per ml. The keratinocyte cell line BALB/MK was cultivated in MCDB 153 medium supplemented with 50 ,uM CaCl2, 0.1 mM ethanolamine, 0.1 mM phosphoethanolamine, epidermal growth factor (10 ng/ml), insulin (5 Rg/ml), 0.5% Chelex-treated fetal calf serum, penicillin (100 IU/ml), streptomycin (100 jLg/ml), and amphotericin B (0.25 jLg/ml).
Animal treatments. Female SENCAR mice, 6 and 9 weeks old, were purchased from Harlan Sprague-Dawley. The backs of the mice were shaved 48 h prior to topical treatment with 10 nmol of TPA (Pharmacia). TPA was applied in 200 RlI of acetone. Control mice were treated with 200 RI of acetone only. Mice were killed by cervical dislocation 3 h after treatment.
In situ hybridization analysis. Formalin-fixed skin tissue was embedded in paraffin, transversally sectioned at 6 to 7 jLm, and mounted onto microscope slides pretreated with 3-aminopropyltriethoxysilane (56) . Sections were deparaffinized in xylene and hydrated (99-90-70% ethanol). Tissue permeabilization and acetylation were carried out as described previously (54) . Sections were prehybridized for 1 to 2 h in a mixture of 50% formamide, 10% dextran sulfate, 3 x SSC (1 x SSC is 0.15 M NaCl plus 0.015 M sodium citrate), 0.2 M dithiothreitol, bovine (F-V) serum albumin (Pharmacia) (2 mg/ml), yeast tRNA (0.2 mg/ml), and single-stranded calf thymus DNA (1 mg/ml). Hybridization was performed at 52°C for 3 h in a humidified chamber with 1 x 10" cpm of 35S-labeled RNA probes in 40 pl of the buffer described above per cm2. cRNA was generated from linearized pGEM-3Z containing the cDNA insert from XB10 (full-length 3' LTR and 309-bp internal VL30 sequences) by using T7 or SP6 RNA polymerase (Promega). 355-labeled cRNA size was estimated to be 50 to 200 bases by formaldehyde-agarose gel electrophoresis. Sections were washed at 52°C twice for 20 min each time in 50% formamide-2 x SSC-10 mM dithiothreitol and then four times for 10 min each time in 2 x SSC at room temperature. Nonspecifically bound probe was removed by treatment with RNase A (100 jig/ml) and RNase Ti (1 jg/ml) (Boehringer Mannheim) at 37°C for 30 min and then washed in 50% formamide and 2 x SSC at 52°C for 10 min. Sections were dehydrated (70-90-99% ethanol), dipped in photographic emulsion (K-5; Ilford), and left for I to 2 weeks at 4°C in the presence of desiccant. The emulsion was developed for 5 min (D19) and fixed (AL4; Kodak), and the sections were counterstained with hematoxylin.
RNA analysis. Total RNA was isolated from SENCAR mouse epidermis by guanidinium thiocyanate-phenol-chloroform extraction as described previously (14) . Total RNA (5 Rg) was fractionated by electrophoresis through formaldehydeagarose gels, blotted onto nylon membranes, and fixed by UV irradiation. The mouse multiple tissue Northern blot was obtained from Clontech (Palo Alto, Calif.). The source of RNA on the tissue blot was BALB/c mice. Northern filters were prehybridized, hybridized, and washed according to standard procedures (62) prior to autoradiography.
Sequencing and reporter plasmid constructs. cDNA inserts of A clones were subcloned into the EcoRI site of pGEM-3Z (Promega). Double-stranded DNA was used for dideoxy sequencing (United States Biochemical Corp.). The construction of BlO.CAT, which contained the 3' U3 region of the VL30 cDNA clone B10 fused to the bacterial chloramphenicol acetyltransferase (CAT) gene, has been described elsewhere (6) . pBLCAT2 and pTlO9.Luc contained the -109 to +51 promoter region of the herpes simplex virus thymidine kinase (TK) promoter fused to the CAT or luciferase (Luc) reporter gene, respectively (43, 47) . VLTRE.Luc, VLX.Luc, and VLY.Luc were created by subcloning oligonucleotides corresponding to the sequences shown below into the HindIII and XhoI sites of pT109.Luc. The integrity of all plasmid constructs was confirmed by sequence analysis. All plasmids were prepared by alkaline lysis, treated with RNase, and purified using Qiagen columns (Diagen).
Transfections and treatments of cells. Preconfluent fibroblasts were transiently transfected by the calcium phosphate precipitation method (24) , while BALB/MK cells were transfected with cationic liposomes (lipofectin; Bethesda Research Laboratories). Cells were grown on 25-cm2 dishes and transfected with S jig of reporter plasmid DNA. The medium was changed 24 h after transfection, and the cells were cultured in the presence or absence of 100 ng of TPA per ml for 16 h. CAT and luciferase activities obtained after transfection were quantified as described previously (62) , and the activities of the different reporter plasmids were normalized to the activity of a cotransfected (1 jLg per transfection) Rous sarcoma virus LTR-driven luciferase (pRSV.Luc) or CAT (pRSV.CAT) reporter plasmid (47) .
Preparation of nuclear extracts and gel shift assay. Nuclear cell extracts were prepared by the method of Struhl et al. (72) . Gel shift analysis was performed with 8 jg of extract protein, 0.8 jLg of poly(dI-dC), 0.8 jig of poly(dG-dC), 0.6 jig of poly(dA-dT), and 30,000 to 40,000 cpm of 32P-labeled oligonucleotide in 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7.8)-80 mM KCl-4 mM MgCl2-4%
Ficoll. The probe and competitor were added together, and the binding reactions were then incubated for 30 min at room temperature. For some protein-DNA binding experiments (see Fig. 5 ), binding reactions and nuclear extract preparation were done in the presence of leupeptin (10 p.g/ml), 5 pLM pepstatin (Boehringer), and aprotinin (Bayer, Inc.) (100 protein kinase K inhibiting units [KIU]/ml). The resulting protein-DNA complexes detected with the VLX probe were resolved on a preelectrophoresed 5% polyacrylamide gel (29:1), with 0.5 x TBE (45 mM Tris-borate, 0.5 mM EDTA) as the running buffer. Protein-DNA complexes detected with the VLY and the NF-KB probes were resolved as described above but with I x TGE (50 mM Tris, 2.7 mM EDTA, 380 mM glycine) as the running buffer.
Oligonucleotides and antibodies used in gel shift analysis. The extracts were preincubated with different antibodies for 30 min at 4°C prior to gel shift analysis. Antibodies recognizing p65(NF-KB) or c-Rel were purchased from Santa Cruz Biotechnology, Inc. These affinity-purified polyclonal antibodies were raised against an amino terminal peptide of human p65 and a carboxy terminal peptide of murine c-Rel, respectively (4, 31) . Complementary synthetic oligonucleotides were syn-VOL. 68, 1994 on Nucleotide sequence accession numbers. The nucleotide sequences reported in this article have been submitted to the GenBank/EMBL data bank under accession numbers X75481 and X75482.
RESULTS
Induction of VL30 mRNA expression specifically in mouse epidermis. By differential screening of a mouse epidermal cDNA library, we previously isolated several cDNA clones corresponding to members of the VL30 family that showed induced expression in mouse epidermis 4 h after a single topical application of the skin tumor promoter TPA (8) . The localization of mRNA expression before and after treatment with 10 nmol of TPA was studied by the in situ hybridization technique. As a source of a VL30-specific probe, we used a 929-bp-long probe that corresponded to the 3' LTR and 309 bp of internal sequences of a TPA-responsive VL30 clone designated B10 (6) . BlO cRNA probes labeled with 35S in either antisense or sense orientation were synthesized. Figure 1 shows that the site of induced VL30 expression was the keratinocytes in the epidermis, whereas in dermal fibroblasts no significant VL30 expression was detected. VL30 mRNA was induced in both basally and suprabasally located differentiating keratinocytes (Fig. IA) . Enhanced VL30 expression was also seen in keratinocytes within the hair follicles (Fig. IB) . In untreated skin (Fig. 1C) , VL30 expression was very low and did not exceed background level. As TPA applied topically penetrates the epidermis (2, 58), this result indicated that the mechanism behind TPA-induced VL30 transcription is cell type dependent.
The function of a TPA response element within a U3 region expressed in the epidermis is cell type dependent. We previously used the U3 region of the VL30 clone BIG to identify sequences mediating TPA-induced VL30 transcription in the keratinocyte cell line BALB/MK (6) . The SV2.CAT plasmid. This plasmid contained the CAT gene under the control of the simian virus 40 promoter and enhancer (43) . As a negative control, we used the parental CAT reporter plasmid (O.CAT), which lacked promoter and enhancer sequences. This result indicated that a VL30 U3 region, which was isolated by a method that selected for VL30 elements induced by TPA in keratinocytes in vivo, could mediate transcription in a keratinocyte cell line but not in a fibroblast cell line when analyzed in vitro. A 39-bp VL30 TPA response element (VLTRE), which is functional in keratinocytes, was previously identified within the BIO U3 region (6) . To determine whether this response element alone was sufficient to mediate a cell type-specific response, a plasmid containing the herpes simplex virus thymidine kinase promoter (TK) and a luciferase reporter gene under the control of the VLTRE was transiently transfected into keratinocytes and fibroblasts. This construct (VLTRE.Luc, schematically shown in Fig. 3 ) mediated TPA-induced transcription in keratinocytes, whereas it was inactive as a TPA response element in fibroblasts (Fig. 3 ). This result indicated that the transcriptional activity of VLTRE was controlled by cell type-dependent trans activation in TPA-treated keratinocytes. The TPAresponsive phenotype, with regard to induced transcription mediated by VLTRE, is not restricted to the BALB/MK cell line. (As we have previously shown, VLTRE is functional in primary human keratinocytes [6] .) Furthermore, no induced reporter gene activity in response to TPA was obtained when BIO.CAT and VLTRE.Luc were analyzed in two additional fibroblast cell lines, BALB/3T3 and NIH 3T3 (9 68, 1994 on October 20, 2017 by guest http://jvi.asm.org/
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Previous results have indicated that two nuclear proteinbinding sequences within VLTRE collaborate in mediating TPA-induced transcription in keratinocytes (6) . To determine whether either of these two sequences alone was able to mediate TPA-induced transcription, two additional plasmid constructs, designated VLX.Luc and VLY.Luc (Fig. 3) , were made. These plasmids were found to be nonresponsive to TPA treatment in both Swiss/3T3 and BALB/MK cells (Fig. 3) . This result supported the conclusion that the presence of both the VLX-and the VLY-binding sites on the same template was essential for TPA-induced VL30 transcription in keratinocytes.
The VLY sequence is a target for TPA-induced c-Rel/NF-KB-binding activity in BALB/MK cells but not in Swiss/3T3 cells. Given the functional importance of VLTRE, we employed gel shift analysis in order to identify the proteins binding to this sequence. The VLY-binding site contained a sequence, GTACTT'TCCC, which was identical to a previously identified DNA element involved in TPA-induced transcription of the human urokinase gene (26) . Hansen et al. designated this DNA sequence the Rel related binding element (RRBE) since it was found to bind both NF-KB(p50/p65) and a novel complex between the p65 subunit of NF-KB and c-Rel (26) . Figure 4A shows that an oligonucleotide corresponding to the VLY sequence was the target for a transient TPAinduced binding activity in BALB/MK cells, which reached a maximum 1 h after the treatment. Two closely migrating complexes, designated A, and a faster-migrating complex, designated B, were detected with the VLY probe. Figure 4B shows that formation of both A and B complexes was inhibited by antibodies specific for the p65 subunit of NF-KB, while complex formation of A but not B was inhibited by antibodies specific for c-Rel. Interestingly, with nuclear extracts prepared from untreated and TPA-treated Swiss/3T3 cells, no complexes comigrating with A and B were detected (Fig. 5A ). When nuclear extracts were prepared from BALB/MK and Swiss/3T3 cells in the presence different protease inhibitors (see Materials and Methods), a fast-migrating complex was formed. This complex formation (indicated with an asterisk in Fig. SA) was not affected by the TPA treatment; nor was it supershifted or abolished when antibodies specific for p65 and c-Rel were included in the binding reaction. We next compared the complex formation observed with the VLY sequence with that generated by the classical NF-KB-binding site present in the enhancer of the K light chain gene (66) . Figure 5B shows that this type of NF-KB-binding site formed a TPA-induced complex in both BALB/MK and Swiss/3T3 nuclear extracts. This complex, designated B', comigrated with complex B and was recognized by antibodies specific for p65, while no supershift or abolished complex formation was obtained in the presence of the c-Rel-specific antibodies (Fig. 5B) . These results suggested that the VLY sequence was a target for TPA-induced binding activity of a c-Rel/p65 heterodimer (complex A) as well as a p65-containing complex (B) in keratinocytes but not in fibroblasts. We did not detect any c-Rel/p65 heterodimercontaining complex when the KB sequence was used as probe. However, the NF-KB-binding site formed a p65-containing complex (B') which lacked the c-Rel component in both TPA-stimulated keratinocytes and fibroblasts. This result was intriguing since it implied that the B or the B' complex contained a protein which together with p65 could distinguish between VLY and the NF-KB-binding site present in the enhancer of the K light chain gene. The use of antibodies specific for the p50 subunit may resolve whether B and/or B' contained a factor different from a p65/pSO heterodimer. within VLTRE is the VLX-binding sequence (shown in Fig. 5 ). We previously showed that this sequence formed a large number of complexes containing proteins related to members of the CREB and Jun families of transcription factors (7) . Figure 5C shows gel shift analysis using an oligonucleotide corresponding to the VLX-binding site as the probe. The individual nature of these complexes has been studied in gel shift analysis using CREB-c-Jun-, JunB-, and JunD-specific antibodies and bacterially expressed CREB (7) . Use of an excess of unlabeled oligonucleotides corresponding to VLXand VLY-binding sites and a consensus CRE present in the choriogonadotropin ox gene (oCG-CRE) (17) as competitors confirmed that the proteins binding to VLX were related to CREB proteins (Fig. SC) (6) . Figure 6 shows that aligned 3' LTR sequences of these clones displayed a low rate of divergence, although differences included nucleotide substitutions, deletions, and short insertions (ranging between 5 and 23 bp). These types of sequence differences were typical of the heterogeneity found between distinct VL30 elements and were not indicative of the sequence variation normally associated with alternative processing pathways of a single RNA precursor species. Thus, this result led us to conclude that at least three VL30 sequences that were TPA inducible in epidermis were encoded by distinct, independent retrotransposon elements in the genome. The VLTRE sequence (boxed in Fig. 6 (27) . The U3 regions present in three distinct genomic VL30 clones, Tlevl (51), VM-1 (33) , and VLS-1 (60), constituted U3 subgroup II (U311). The TPAinducible VL30 elements which were characterized in epidermis together with some previously characterized VL30 elements designated BVL-1, VL11, and Vleco constituted the third U3 subgroup (U3111). BVL-1, VL11, and VLeco were isolated from genomic libraries (28, 29, 34) . Vleco was a solo LTR that was found to be integrated within a murine leukemia provirus (29) . Five Tissue-specific expression of distinct U3 subgroups. Autoradiographs of Northern blots analysis using RNA were prepared from different mouse tissues (the RNA sources are given in Materials and Methods). Hybridizations were performed with oligonucleotide probes (for sequences, see Fig. 8 ) specific for each of the defined U3 subgroups or a U3-nonspecific probe (LTR) corresponding to the full-length 3' LTR and 309-bp internal sequences of the VL30 clone B10. The upper and lower arrows indicate VL30 transcripts corresponding to 10 and 5.6 kb, respectively. For comparison, hybridization to a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe is included. (A) VL30-specific signals on Northern blots generated after repeated hybridizations and rehybridizations of a single tissue blot with group-specific probes. (B) Northern blot analysis performed (as for panel A) with U3-specific probes and RNA preparations from untreated mouse epidermis (C) and 4 h after a single topical treatment with 10 nmol of TPA (T).
containing the full-length 3' LTR and a 309-bp internal sequence. Figure 9A shows that this probe recognized VL30 transcripts from all tissues tested except the brain. In addition to the 5.6-kb transcript, we observed a highly expressed RNA transcript of approximately 10 kb in heart and skeletal muscle. This hybridization pattern is in agreement with that obtained by Harrigan et al. (27) . The tissue blot was then rehybridized with probes specific for each U3 subgroup. A U31-specific probe hybridized predominantly to a 5.6-kb VL30 RNA in spleen. A relatively weak signal corresponding to this U3 subgroup was also obtained using lung poly(A)+ RNA. Two different U311-specific probes did not give rise to significant signals in any tissue analyzed. Two U3111-specific probes hybridized weakly to transcripts in all tissues examined except brain and muscle. A more intense signal was detected in lung poly(A)+ RNA with these probes. A U3IV-specific probe predominantly recognized the 5.6-kb transcript in poly(A)+ RNA from heart and the 10-kb transcripts in poly(A)+ RNA from heart and muscle. Relatively weak signals were also generated by this probe in lung, liver, and testis samples. As a reference, the filter was rehybridized with a probe that recognized glyceraldehyde-3-phosphate dehydrogenase mRNA (21) . These results showed that members of the VL30 family were expressed in a tissue-specific manner and that a rough assignment of expressed VL30 elements to different U3 subgroups could be done. Assuming that the nonspecific LTR probe used recognized all expressed VL30 U3 regions, a comparison of the relative signal intensities (data not shown) indicated that additional VL30 members not included in the four subgroups were expressed, for example, in tissues such as kidney.
TPA inducibility of VL30 in epidermis correlates with the presence of VLTRE. To test the correlation between regulated VL30 expression and the presence of a characterized response element, we prepared RNA from untreated and TPA-treated mouse epidermis. Figure 9B shows that U3111-and U3IV-but not U31-and U311-specific probes recognized TPA-induced VL30 expression in epidermis. This expression pattern correlated with the presence of a conserved VLTRE in U3111 and U3IV, while in U31 and U3II the corresponding region contained conserved core and OCT motifs, respectively (see the discussion below). Enhancer design of U3 subgroups. Figure 10 illustrates that the sequence variation between the U3 subgroups correlated with variations in the number and types of sequence motifs known to be involved in VL30 transcriptional regulation as well as to a large number of putative binding sites for other known transcription factors. VL30 U3 regions corresponding to each U3 subgroup were marked as follows. Retinoic acid response elements (boxed within the B1O U3 region), which have been shown to bind heterodimers of retinoic acid receptor (RAR) and the retinoid X receptor (RXR), mediated retinoic acid-induced B10 transcription in normal human keratinocytes but not in normal skin fibroblasts (32) . The corresponding sequences (also boxed) in the other U3 subgroups differ from those in the B10 U3 region in the nucleotide spacing between the direct repeats of these putative retinoic acid elements. Moreover, CRE-and Jun-binding sequences, one of which is identical to the VLX site within the VLTRE, are located within the B10 U3 region. These sites cooperated in mediating adrenocorticotropin-and forskolin-induced transcription in the steroidogenic adrenal cell line Y1 but not in the BALB/MK, Swiss/3T3, or Hepal cell line (7) . During the characterization of TPA-, cAMP-, and retinoic acid-induced transcription, we encountered other binding activities in nuclear extracts recognizing sequence motifs within the B10 U3 region (9) . These DNA motifs were similar to the CArG box and API-and NFl-binding sequences (Fig. 10) . Formation of the complex with oligonucleotides corresponding to these sequence motifs as probes was inhibited by an excess of unlabeled oligonucleotides corresponding to the serum response element in the c-fos promoter, the APi-binding site in the collagenase promoter, and a consensus NFl-binding site, respectively (9) . The activities of the CREB and Jun-binding sites, the CArG box, and the putative APi-binding motif within the RVL3 U3 region (U3IV) have also been studied in Rat-1 fibroblasts by Lenormand et al. (39) . Owen et al. identified two juxtaposed binding sites for nuclear factors which mediated induced NVL3 (U31) transcription in response to an activated Ha-ras gene in NIH 3T3 fibroblasts (50) . These two sites resembled the Ets-and APi-binding sites, respectively (55) .
The site resembling an Ets-binding sequence has been shown to be recognized by a 120-kDa protein designated ras-responsive factor-1 (55 the core sequence, and a consensus OCT sequence (Fig. 10 ) (20, 35, 70, 71) .
DISCUSSION
One characteristic feature of VL30 retrotransposons is the remarkable inducibility of their expression by a wide range of agents and physiological stimuli. One possibility is that this feature is determined by the structural diversity of VL30 U3 sequences. In this work, we show that a homology study of 17 sequenced VL30 LTRs reveals one interesting observation: it is possible to organize VL30 retrotransposons into four distinct U3 subgroups (U31, U311, U311, and U3IV). A sequence alignment of all groups reveals that each U3 subgroup contains different variants and/or a combination of response elements known to regulate VL30 transcription. We have previously identified response elements that determine cell type-specific VL30 transcription in response to retinoic acid in keratinocytes as well as cAMP-induced transcription in steroidogenic adrenal cells (7, 32 Since it is generally believed that the VL30 expression level is high in all tissues, we wanted to test the possibility that VL30 expression appears ubiquitous when expression is analyzed with a probe recognizing all VL30 members but cell type specific when U3-specific probes are used. Indeed, this pattern of VL30 expression is evident in Northern blot analyses of RNA isolated from eight different mouse tissues.
U31 is found to be specifically expressed in spleen. One VL30 element within U31 that is known to be expressed (element 1.5) has been isolated among genes specifically induced by cAMP and glucocorticoids in T cells (27) . Specific to this U3 subgroup are conserved LVb and core motifs which have been shown to mediate T cell-specific expression of the Moloney murine leukemia virus (70, 71) . These results indicate that U31 might be expressed in the T-cell population of spleen. Another VL30 member within U31 is NVL3, which is expressed in NIH 3T3 fibroblasts and has been used to study induced transcription in response to an activated Ha-ras oncogene and TPA in these cells (50) . The correlation between Ha-Ras/TPA-induced transcription in fibroblasts and the high level of constitutive expression in spleen tissue remains to be determined. However, it is interesting that both the LVb and the core motifs in the Moloney murine leukemia virus LTR are essential for TPA-induced transcription in Jurkat T cells (71) .
Members within U311 have not been reported to be expressed, and accordingly no expression of these U3 regions is found in the tissues examined in this study. The fact that all tissues (except epidermis) have been taken from the BALB strain of mice and that the members of U3 subgroup II are cloned from genomic libraries made from the same strain argues against the possibility that a mouse strain-specific difference in the existence of genomic U311 members can explain the lack of expression. From the structural analysis of U3 regions within this subgroup, it is evident that many transcriptional regulatory sequence motifs are present, such as a TATA box, RAR/RXR-, CREB/Jun-, NFI-, and c-rel/NF-KB-binding sites. We therefore favor the hypothesis that members of this U3 subgroup are transcriptionally competent, but it remains to be determined in which cell type and/or by which intracellular signal pathway their expression is regulated.
Schiff et al. have used the method of in situ hybridization to analyze the distribution of VL30 expression in mice from late embryonic stages (65) . In their study, it was shown that the level of VL30 expression is high in steroidogenic tissues and detectable in the epithelial tissue layers of most internal organs. The only U3 regions within U3111 that have been shown to be expressed are the ones described in this study. The fact that these U3 regions correspond to VL30 elements expressed in epithelial tissue (epidermis) suggests that the relatively low level of constitutive expression of U3111 detectable in most organs may arise from expression in the epithelial layers of these organs. However, the highest relative level of expression of U3111 is detected in lung and expression of both U3111 and U3IV is detected in the testis, which is a steroidogenic organ. Members within U3IV have been isolated from steroidogenic cells, and we have used BIO (belonging to U3111) to identify sequence motifs that mediate steroidogenic cellspecific transcription. U311I expression is found to be relatively weak in testes. However, it should be noted that high levels of VL30 expression in Leydig cells of testes can be detected after administration of human chorionic gonadotropin, a treatment mimicking a luteinizing hormone stimulation (65) .
Constitutive high levels of U31V expression are detected specifically in cardiac and skeletal muscles. The LTRs corresponding to this U3 subgroup may therefore be useful in the elucidation of transcriptional regulatory mechanisms specific for muscle genes in both skeletal and cardiac muscle cells. In this respect, it is intriguing that U3IV specifically contains two copies of the CArG element, which has been shown to be one element involved in muscle-specific gene regulation (45, 53, 64) . The finding that U3 subgroup IV shows a higher relative level of expression in heart than in skeletal muscle and the identification of a heart-specific 5.6-kb VL30 transcript are observations that can be explored in studies concerning differences in the transcriptional regulation between skeletal muscle and cardiac muscle cells. The U3IV subgroup has also been shown to respond to cAMP, TPA, epidermal growth factor, and Ca2+ agonist-induced transcription in cell types other than muscle cells (39, 65) . One possibility is that cardiac cells have constitutive activation of a particular signal pathway which is utilized for inducible gene transcription in other cell types.
The 100 to 200 VL30 members are dispersed in the mouse genome (11, 36, 37) . It is therefore likely that mechanisms other than trans repression and/or trans activation contribute to the individual patterns of constitutive expression in different mouse tissues. The lack of detectable VL30 expression in brain might be an indication of such a cis-acting regulatory mechanism. However, it is possible that the fraction of VL30 elements which is present in a transcriptionally accessible chromatin configuration in a given situation is only transcribed when it contains the appropriate transcription factor binding sites which are utilized in that particular cell type. The high level of VL30 expression in kidney that can be detected with a probe recognizing all VL30 members and the relatively low level of VL30 expression in this organ detectable with the U3-specific probes argue for the existence of additional U3 subgroups. Another indication of this possibility is the finding that the U3 region of VLovl shows the highest sequence similarity to members of U3IV but to a lesser degree (<80%) than the other members within this U3 subgroup.
Retroviral recombination in general is thought to require prior transcription of the virus and packaging of the respective RNA molecules (30, 73) . Thus, transcriptional activation and subsequent packaging are prerequisites and the driving force for recombinogenic activity. Of the known retrotransposon families, VL30s are the only ones which so far have been shown to be packageable and hence rescuable as C-type pseudoviruses (37) . The relatively high number of VL30 family members having variable U3 regions is therefore most likely a consequence of a high rate of recombination, errors during replication, and transposition into the germ line (37) . One established theory is that a DNA entity which is successful in replicating itself could stay in the genome as a "selfish" DNA (18, 49, 63) . VL30 members may therefore prosper in the mouse genome by retaining and/or acquiring specific binding sites for transcription factors, or combinations thereof. We present results here that strongly support the conclusion that VL30 members are transcribed independently in a stimulusand cell type-specific manner and that the regulation of VL30 transcription is dependent on both the presence of specific cis elements within the U3 region and cell type-specific differences in the activity of transacting factors. Thus, the close association between transcription and recombination, the existence of U3 with variations in transcription factor binding sites, and the expression of these in a cell type-and stimulus-specific manner implies a novel approach to the study of cell type-specific transcription by comparing expressed U3 regions with other U3 regions that are not affected by the particular transcriptional regulatory mechanism of interest.
